External Email - Use Caution        

Hello all,

I am using FreeSurfer to measure specific cortical parcellations and 
subcortical segmentations in a medium-sized dataset (over 150 scans). About a 
fifth of the scans include cortical lesions (ischemic stroke, hemorrhagic 
stroke, focal traumatic injuries, neoplasm) that visibly disrupt recon-all's 
white matter surface and the pial surface locally at the lesion.

Assuming there is no midline shift, does the recon-all processing stream 
perform segmentations and parcellations in each hemisphere independently? Or, 
could a unilateral lesion impact segmentation/parcellation on the contralateral 
side?

For segmentation/parcellation measurements on the side ipsilateral to a lesion, 
how robust are recon-all's measurements in non-lesioned regions? For instance, 
are hippocampal volume measurements impacted by a cortical lesion in the 
frontal convexity? Or a lesion in a lateral temporal gyrus? Are there any 
general guides on how close a lesion can be to a ROI before automated 
measurements are invalid?

Thank you much in advance,
Brian
--
L. Brian Hickman, MD, MSc

________________________________

UCLA HEALTH SCIENCES IMPORTANT WARNING: This email (and any attachments) is 
only intended for the use of the person or entity to which it is addressed, and 
may contain information that is privileged and confidential. You, the 
recipient, are obligated to maintain it in a safe, secure and confidential 
manner. Unauthorized redisclosure or failure to maintain confidentiality may 
subject you to federal and state penalties. If you are not the intended 
recipient, please immediately notify us by return email, and delete this 
message from your computer.
_______________________________________________
Freesurfer mailing list
Freesurfer@nmr.mgh.harvard.edu
https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer
The information in this e-mail is intended only for the person to whom it is 
addressed.  If you believe this e-mail was sent to you in error and the e-mail 
contains patient information, please contact the Mass General Brigham 
Compliance HelpLine at https://www.massgeneralbrigham.org/complianceline 
<https://www.massgeneralbrigham.org/complianceline> .
Please note that this e-mail is not secure (encrypted).  If you do not wish to 
continue communication over unencrypted e-mail, please notify the sender of 
this message immediately.  Continuing to send or respond to e-mail after 
receiving this message means you understand and accept this risk and wish to 
continue to communicate over unencrypted e-mail. 

Reply via email to